Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Deferoxamine mesylate, Iron chelator
Deferoxamine mesylate, Iron chelator from Abcam
Be the first to write a review!
Citations:
(13)
Supplier Page
Supplier Page from
Abcam for
Deferoxamine mesylate, Iron chelator
Description
Iron chelator
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Deferoxamine mesylate, Iron chelator
Company
Abcam
Price
Supplier Page
View Company Product Page
Catalog Number
ab120727
Quantity
1 g
Type
Chemical
Molecule Name
Deferoxamine mesylate
Add to Compare List
Abcam
Discovery Drive
Cambridge Biomedical Campus
Cambridge
CB2 0AX
United Kingdom
Phone
: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600
Company Profile
Website:
http://www.abcam.com
Citations (13)
(1)
Tumors hijack macrophages for iron supply to promote bone metastasis and anemia
Cell
October 30, 2025
Yujiao Han, Hirak Sarkar, Zhan Xu, Sereno Lopez-Darwin, Yong Wei, Xiang Hang, Fengshuo Liu, Kimberley Tran, Wei Wang, Jennifer M. Miller,
et al.
The co-
cultured cells
were treated with 1.5 μM of iron chelator
Deferoxamine mesylate
(DFO,
Abcam
, #
ab120727
), ferroportin (FPN)
inhibitor
VIT-2763
/Vamifeport (Vam,
MedChemExpress
, #
HY-112220
) at indicated concentration,
(2)
Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy
Journal of Clinical Investigation
September 2, 2025
Kodai Nakamura, Huascar Pedro Ortuste Quiroga, Naoki Horii, Shin Fujimaki, Toshiro Moroishi, Keiichi I. Nakayama, Shinjiro Hino, Yoshihiko Saito, Ichizo Nishino, Yusuke Ono
number of
myotubes
containing more than 4
filopodia
to the total number of MyHC+
DAPI
+ nuclei; DFO (
ab120727
,
Abcam
) and FAS (091-00855, FUJIFILM) were used as an iron chelator and iron donor, respectively. For
(3)
Targeting hypoxia-inducible factor-1 in a hypoxidative stress model protects retinal pigment epithelium cells from cell death and metabolic dysregulation
Cell death discovery
August 14, 2025
Schubert A, Lobo Barbosa da Silva ME, Ambrock T, Terosian O, Malyshkina A, Padberg C, Larafa S, Matschke J, Fandrey J, Henning Y.
inhibitors
were used: Ferrostatin-1 (Fer-1;
ab146169
,
Abcam
, Cambridge, UK),
Deferoxamine Mesylate
(
ab120727
,
Abcam
), 2’2-Bipyridyl (D216305-2, Sigma Aldrich),
Vorinostat/SAHA
(
S1047
,
Selleck Chemicals
GmbH, Cologne,
(4)
Superoxide Activates Ferroptosis via the Haber‐Weiss Reaction and Enhances Age‐Related Macular Degeneration
Aging Cell
August 10, 2025
Ying Huang, Zhenxing Zhou, Mengjia Huan, Qi Guo, Xiaoqian Zhang, Ruiqi Lu, Lushu Chen, Xiumiao Li, Jin Yao, Qin Jiang,
et al.
inhibitors
based on our previous investigation (Xu et al. 2023), including 50 μM deferoxamine mesylate (DFO,
ab120727
,
Abcam
), 10 mM ferrostatin‐1 (Fer‐1,
ab146169
,
Abcam
), 20 mM necrostatin‐1 (Nec‐1,
ab141053
,
Abcam
),
(5)
Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy
J Clin Invest
July 1, 2025
Kodai Nakamura, Huascar Pedro Ortuste Quiroga, Naoki Horii, Shin Fujimaki, Toshiro Moroishi, Keiichi I. Nakayama, Shinjiro Hino, Yoshihiko Saito, Ichizo Nishino, Yusuke Ono
number of
myotubes
containing more than 4
filopodia
to the total number of MyHC+
DAPI
+ nuclei; DFO (
ab120727
,
Abcam
) and FAS (091-00855, FUJIFILM) were used as an iron chelator and iron donor, respectively. For
(6)
High taurocholic acid concentration induces ferroptosis by downregulating FTH1 expression in intrahepatic cholestasis of pregnancy
BMC Pregnancy Childbirth
January 9, 2025
Wei-Jian Zeng, Hua-Jing Yang, Ying-Jie Gu, Meng-Nan Yang, Meng-Ru Sun, Sheng-Kai Cheng, Yan-Yan Hou, Wei Gu
FTH1
-overexpressed vectors are outlined in supplementary file 3. Herein, 10 µM of deferoxamine (DFO,
Abcam
, Cat #:
ab120727
), the ferroptosis
inhibitor
, was utilized for 24 h. TCA-induced cell co-treatment with DFO was also
(7)
Quantitative Proteomics of Tissue-Infiltrating T Cells From CRC Patients Identified Lipocalin-2 Induces T-Cell Apoptosis and Promotes Tumor Cell Proliferation by Iron Efflux
Molecular & Cellular Proteomics
January 1, 2024
Rui Che, Qingsong Wang, Minzhe Li, Jian Shen, Jianguo Ji
stimulated and activated with 2 μg/ml PHA (
11249738001
;
Roche
). Cells were treated with deferoxamine (DFO) (
ab120727
;
Abcam
), ferric citrate (FC) (
F3388
;
Sigma–Aldrich
), low-density lipoprotein-cholesterol (LDL-C) (H7960;
(8)
Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells
Cell Death Discov
December 15, 2023
Binjie Yan, Darrell Belke, Yu Gui, Yong-Xiang Chen, Zhi-Sheng Jiang, Xi-Long Zheng
33342 (#
H3570
) were purchased from
Thermo Fisher Scientific
(Ottawa, ON, Canada). Deferoxamine (DFO; #
ab120727
) and
MI-2
(#
ab145047
) were obtained from
Abcam
(Cambridge, MA). Ferrostatin-1 (Fer-1; #A13247), Necrostatin-1
(9)
Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction
Cell death & disease
July 29, 2022
Henning Y, Blind US, Larafa S, Matschke J, Fandrey J.
(Fer-1;
ab146169
,
Abcam
),
Liproxstatin-1
(Lip-1; Cay-
17730
,
Cayman Chemical
),
Deferoxamine Mesylate
(
ab120727
,
Abcam
), 2’2-Bipyridyl (D216305-2, Sigma Aldrich), and DharmaFECT 4
Transfection Reagent
(T-2004-02,
(10)
PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
Journal of experimental & clinical cancer research : CR
November 8, 2021
You JH, Lee J, Roh JL.
calcein acetoxymethyl ester (354,217; Corning Inc., Corning, NY, USA) and iron chelator, deferoxamine (
ab120727
;
Abcam
, Cambridge, UK). The cells were loaded with calcein-AM (8 μg/ml) for 30 min at 37 °C and then
(11)
xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma
Oncology letters
September 1, 2020
Sugiyama A, Ohta T, Obata M, Takahashi K, Seino M, Nagase S.
in DMSO and from
Sigma-Aldrich
; Merck KGaA). A total of 10 mM deferoxamine mesylate (DFO) (cat. no.
ab120727
;
Abcam
) was dissolved in water and 10 mM
Z-VAD-FMK
(Peptide Institute, Inc.) in DMSO. Cytotoxicity
(12)
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
JCI insight
May 7, 2020
Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, Ishikita A, Matsushima S, Koumura T, Yamada KI,
et al
.
Institute.
Rotenone
(R0090) and NAC (A0905) were purchased from Tokyo Chemical Industry. DFO mesylate (
ab120727
) and DXZ hydrochloride (
ab141109
) were purchased from
Abcam
. MFG (M489) was purchased from Dojindo. Echocardiography.
(13)
Chronic diazepam administration increases the expression of Lcn2 in the CNS
Pharmacology Research & Perspectives
February 1, 2017
Tomonori Furukawa, Shuji Shimoyama, Yasuo Miki, Yoshikazu Nikaido, Kohei Koga, Kazuhiko Nakamura, Koichi Wakabayashi, Shinya Ueno
intralipid (20% i.v. fat emulsion).
Deferoxamine mesylate
(DFO), iron chelator, was purchased from
Abcam
(
ab120727
; Cambridge, UK), and was dissolved in saline. Chronic treatment of DZP and DFO To study the effect
<<
<
>
>>
Reviews
Be the First to Write a Review!
Deferoxamine mesylate, Iron chelator from Abcam
Supplier Page
View Company Product Page
Product Specs
Company Info
Citations
Reviews
Back To Top